Mina Nikanjam, MD, PhD
University of California, Los Angeles
2016
$
100000
Cancer Free Generation Career Development Research Grant
Development of a Novel dCK Inhibitor for Leukemia and Lymphoma using PET Imaging
DI82 is a new potential chemotherapy drug which can kill cancer cells by preventing them from making new DNA. The project will look at drug levels in the blood, tumor, and other parts of the body using an imaging machine (PET). The drug will be tested in mice in combination with two other drugs to determine how well they work together to kill tumor cells. This information will be used in a model to predict how much drug to give patients in future human studies.
Support the Journey
When you donate to Tower, you’re not supporting a single study. You’re part of an ecosystem that believes the next breakthrough is out there, waiting for someone to believe in it first. Every gift puts resources directly behind the discoveries that would otherwise never see the light of day.